Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Anterix Inc.ATEX · Entity 4597 | Director | August 28, 2023 | August 30, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Anterix Inc.
Report date August 28, 2023 · Filed August 30, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 17,414 |
Reported balance
After 2023-08-28 transaction · row 1
1 source rowRow 1 · 2023-08-28 · Grant · Acquired 5,209 · Balance 17,414 F1: The restricted stock vests in full on the earlier of (i) August 28, 2024 or (ii) immediately prior to commencement of the Issuer's next annual stockholder meeting; provided, however, that if the vesting would otherwise occur on a date that is closed for trading under the Issuer's Insider Trading Policy, the vesting shall be automatically deemed to occur on the next trading day on which the sale of shares of common stock by the Reporting Person in the open market would be permitted under the Issuer's Insider Trading Policy. |
Filing footnotes · ownership attribution and instrument terms
F1: The restricted stock vests in full on the earlier of (i) August 28, 2024 or (ii) immediately prior to commencement of the Issuer's next annual stockholder meeting; provided, however, that if the vesting would otherwise occur on a date that is closed for trading under the Issuer's Insider Trading Policy, the vesting shall be automatically deemed to occur on the next trading day on which the sale of shares of common stock by the Reporting Person in the open market would be permitted under the Issuer's Insider Trading Policy.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 28, 2023 Filed Aug 30, 2023 17:33 UTC | Anterix Inc. ATEX · Entity 4597 | GrantCommon Stock | 5,209 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-047761 · doc4.xml · nonDerivative · entry 1 Haller Greg · CIK 0001756620 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,414 F1 · shares: The restricted stock vests in full on the earlier of (i) August 28, 2024 or (ii) immediately prior to commencement of the Issuer's next annual stockholder meeting; provided, however, that if the vesting would otherwise occur on a date that is closed for trading under the Issuer's Insider Trading Policy, the vesting shall be automatically deemed to occur on the next trading day on which the sale of shares of common stock by the Reporting Person in the open market would be permitted under the Issuer's Insider Trading Policy. Read SEC document |
| August 10, 2022 Filed Aug 12, 2022 18:09 UTC | Anterix Inc. ATEX · Entity 4597 | GrantCommon Stock | 3,595 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-045686 · doc4.xml · nonDerivative · entry 1 Haller Greg · CIK 0001756620 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,205 F1 · shares: The restricted stock vests in full on the earlier of (i) August 10, 2023 or (ii) immediately prior to commencement of the Issuer's next annual stockholder meeting; provided, however, that if the vesting would otherwise occur on a date that is closed for trading under the Issuer's Insider Trading Policy, the vesting shall be automatically deemed to occur on the next trading day on which the sale of shares of common stock by the Reporting Person in the open market would be permitted under the Issuer's Insider Trading Policy. Read SEC document |
| August 06, 2021 Filed Aug 10, 2021 18:47 UTC | Anterix Inc. ATEX · Entity 4597 | GrantCommon Stock | 2,834 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-050688 · doc4.xml · nonDerivative · entry 1 Haller Greg · CIK 0001756620 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,610 F1 · shares: The restricted stock vests in full on the earlier of (i) August 6, 2022 or (ii) immediately prior to commencement of the Issuer's next annual stockholder meeting; provided, however, that if the vesting would otherwise occur on a date that is closed for trading under the Issuer's Insider Trading Policy, the vesting shall be automatically deemed to occur on the next trading day on which the sale of shares of common stock by the Reporting Person in the open market would be permitted under the Issuer's Insider Trading Policy. Read SEC document |
| September 02, 2020 Filed Sep 3, 2020 18:17 UTC | Anterix Inc. ATEX · Entity 4597 | GrantCommon Stock | 2,072 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-049538 · doc4.xml · nonDerivative · entry 1 Haller Greg · CIK 0001756620 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,776 F1 · shares: The restricted stock vests in full on the earlier of (i) September 2, 2021 or (ii) immediately prior to commencement of the Issuer's next annual stockholder meeting; provided, however, that if the vesting would otherwise occur on a date that is closed for trading under the Issuer's Insider Trading Policy, the vesting shall be automatically deemed to occur on the next trading day on which the sale of shares of common stock by the Reporting Person in the open market would be permitted under the Issuer's Insider Trading Policy. Read SEC document |
| August 06, 2019 Filed Aug 8, 2019 17:50 UTC | Anterix Inc. ATEX · Entity 4597 | GrantCommon Stock | 2,094 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-045189 · doc4.xml · nonDerivative · entry 1 Haller Greg · CIK 0001756620 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,704 F1 · shares: The restricted stock vests in full on the earlier of (i) August 6, 2020 or (ii) immediately prior to commencement of the Issuer's next annual stockholder meeting; provided, however, that if the vesting would otherwise occur on a date that is closed for trading under the Issuer's Insider Trading Policy, the vesting shall be automatically deemed to occur on the next trading day on which the sale of shares of common stock by the Reporting Person in the open market would be permitted under the Issuer's Insider Trading Policy. Read SEC document |
| November 07, 2018 Filed Nov 8, 2018 17:00 UTC | Anterix Inc. PDVW · Entity 4597 | GrantCommon Stock | 1,610 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-057768 · doc4.xml · nonDerivative · entry 1 Haller Greg · CIK 0001756620 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,610 F1 · shares: The restricted stock vests in full on the earlier of (i) August 7, 2019 or (ii) immediately prior to commencement of the Issuer's next annual stockholder meeting; provided, however, that if the vesting would otherwise occur on a date that is closed for trading under the Issuer's Insider Trading Policy, the vesting shall be automatically deemed to occur on the next trading day on which the sale of shares of common stock by the Reporting Person in the open market would be permitted under the Issuer's Insider Trading Policy. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.